Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study

Molecular and Cellular Proteomics

Volumn 12, Issue 7, 2013, Pages 2006-2020

  Megger, Dominik A ^a   Bracht, Thilo ^a   Kohl, Michael ^a   Ahrens, Maike ^a   Naboulsi, Wael ^a   Weber, Frank ^b   Hoffmann, Andreas Claudius ^b   Stephan, Christian ^a   Kuhlmann, Katja ^a   Eisenacher, Martin ^a   Schlaak, Jörg F ^b   Baba, Hideo A ^b   Meyer, Helmut E ^a   Sitek, Barbara ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETAINE HOMOCYSTEINE METHYLTRANSFERASE; CHLORIDE CHANNEL; GELSOLIN; INORGANIC PYROPHOSPHATASE; LUNG RESISTANCE PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; FEMALE; GEL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER; LIVER TUMOR; METABOLISM; MIDDLE AGED; PROCEDURES; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; YOUNG ADULT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; YOUNG ADULT;

EID: 84880067735     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.028027     Document Type: Article

References (89)

1. El-Serag, H. B., and Mason, A. C. (1999) Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 340, 745-750 (Pubitemid 29114292)
2. Di Bisceglie, A. M., Sterling, R. K., Chung, R. T., Everhart, J. E., Dienstag, J. L., Bonkovsky, H. L., Wright, E. C., Everson, G. T., Lindsay, K. L., Lok, A. S., Lee, W. M., Morgan, T. R., Ghany, M. G., and Gretch, D. R. (2005) Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J. Hepatol. 43, 434-441 (Pubitemid 41111424)
3. Oka, H., Saito, A., Ito, K., Kumada, T., Satomura, S., Kasugai, H., Osaki, Y., Seki, T., Kudo, M., and Tanaka, M. (2001) Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein. J. Gastroenterol. Hepatol. 16, 1378-1383 (Pubitemid 34107406)
4. Liebman, H. A., Furie, B. C., Tong, M. J., Blanchard, R. A., Lo, K. J., Lee, S. D., Coleman, M. S., and Furie, B. (1984) Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N. Engl. J. Med. 310, 1427-1431 (Pubitemid 14101298)
5. Pei, Y., Zhang, T., Renault, V., and Zhang, X. (2009) An overview of hepatocellular carcinoma study by omics-based methods. Acta Biochim. Biophys. Sin. 41, 1-15
6. Liu, Z., Ma, Y., Yang, J., and Qin, H. (2011) Upregulated and downregulated proteins in hepatocellular carcinoma: a systematic review of proteomic profiling studies. OMICS 15, 61-71
7. Orimo, T., Ojima, H., Hiraoka, N., Saito, S., Kosuge, T., Kakisaka, T., Yokoo, H., Nakanishi, K., Kamiyama, T., Todo, S., Hirohashi, S., and Kondo, T. (2008) Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma. Hepatology 48, 1851-1863
8. Yokoyama, Y., Kuramitsu, Y., Takashima, M., Iizuka, N., Toda, T., Terai, S., Sakaida, I., Oka, M., Nakamura, K., and Okita, K. (2004) Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 4, 2111-2116 (Pubitemid 38880376)
9. Takashima, M., Kuramitsu, Y., Yokoyama, Y., Iizuka, N., Toda, T., Sakaida, I., Okita, K., Oka, M., and Nakamura, K. (2003) Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virusrelated hepatocellular carcinoma. Proteomics 3, 2487-2493 (Pubitemid 38010125)
10. Zhang, D., Lim, S. G., and Koay, E. S. (2007) Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma. Int. J. Oncol. 31, 577-584
11. Corona, G., De Lorenzo, E., Elia, C., Simula, M. P., Avellini, C., Baccarani, U., Lupo, F., Tiribelli, C., Colombatti, A., and Toffoli, G. (2010) Differential proteomic analysis of hepatocellular carcinoma. Int. J. Oncol. 36, 93-99
12. Zubaidah, R. M., Tan, G. S., Tan, S. B., Lim, S. G., Lin, Q., and Chung, M. C. (2008) 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis. Proteomics 8, 5086-96
13. Sun, W., Xing, B., Sun, Y., Du, X., Lu, M., Hao, C., Lu, Z., Mi, W., Wu, S., Wei, H., Gao, X., Zhu, Y., Jiang, Y., Qian, X., and He, F. (2007) Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol. Cell. Proteomics 6, 1798-1808 (Pubitemid 350031681)
14. Lee, I. N., Chen, C. H., Sheu, J. C., Lee, H. S., Huang, G. T., Yu, C. Y., Lu, F. J., and Chow, L. P. (2005) Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry. J. Proteome Res. 4, 2062-2069
15. Minagawa, H., Yamashita, T., Honda, M., Tabuse, Y., Kamijo, K., Tsugita, A., and Kaneko, S. (2008) Comparative analysis of proteome and transcriptome in human hepatocellular carcinoma using 2D-DIGE and SAGE. Protein J. 27, 409-419
16. Sun, Y., Mi, W., Cai, J., Ying, W., Liu, F., Lu, H., Qiao, Y., Jia, W., Bi, X., Lu, N., Liu, S., Qian, X., and Zhao, X. (2008) Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma. J. Proteome Res. 7, 3847-3859
17. Chen, N., Sun, W., Deng, X., Hao, Y., Chen, X., Xing, B., Jia, W., Ma, J., Wei, H., Zhu, Y., Qian, X., Jiang, Y., and He, F. (2008) Quantitative proteome analysis of HCC cell lines with different metastatic potentials by SILAC. Proteomics 8, 5108-5118
18. Chaerkady, R., Harsha, H. C., Nalli, A., Gucek, M., Vivekanandan, P., Akhtar, J., Cole, R. N., Simmers, J., Schulick, R. D., Singh, S., Torbenson, M., Pandey, A., and Thuluvath, P. J. (2008) A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma. J. Proteome Res. 7, 4289-4298
19. Li, C., Ruan, H. Q., Liu, Y. S., Xu, M. J., Dai, J., Sheng, Q. H., Tan, Y. X., Yao, Z. Z., Wang, H. Y., Wu, J. R., and Zeng, R. (2012) Quantitative proteomics reveal up-regulated protein expression of the SET complex associated with hepatocellular carcinoma. J. Proteome Res. 11, 871-885
20. Lee, S., Kwon, M. S., Lee, H. J., Paik, Y. K., Tang, H., Lee, J. K., and Park, T. (2011) Enhanced peptide quantification using spectral count clustering and cluster abundance. BMC Bioinformatics 12, 423
21. Meding, S., Nitsche, U., Balluff, B., Elsner, M., Rauser, S., Schöne, C., Nipp, M., Maak, M., Feith, M., Ebert, M. P., Friess, H., Langer, R., Höfler, H., Zitzelsberger, H., Rosenberg, R., and Walch, A. (2012) Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging. J. Proteome Res. 11, 1996-2003
22. Le Faouder, J., Laouirem, S., Chapelle, M., Albuquerque, M., Belghiti, J., Degos, F., Paradis, V., Camadro, J. M., and Bedossa, P. (2011) Imaging mass spectrometry provides fingerprints for distinguishing hepatocellular carcinoma from cirrhosis. J. Proteome Res. 10, 3755-3765
23. Sobin, L. H., Gospodarowicz, M. K., and Wittekind, C. (2009) TNM Classification of Malignant Tumours, 7th ed., Wiley-Blackwell, New-York
24. Klose, J., and Kobalz, U. (1995) Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis 16, 1034-1059
25. Sitek, B., Lüttges, J., Marcus, K., Klöppel, G., Schmiegel, W., Meyer, H. E., Hahn, S. A., and Stühler, K. (2005) Application of fluorescence difference gel electrophoresis saturation labelling for the analysis of microdissected precursor lesions of pancreatic ductal adenocarcinoma. Proteomics 5, 2665-2679 (Pubitemid 40966494)
26. Poschmann, G., Sitek, B., Sipos, B., Ulrich, A., Wiese, S., Stephan, C., Warscheid, B., Klöppel, G., Vander Borght, A., Ramaekers, F. C., Meyer, H. E., and Stuhler, K. (2009) Identification of proteomic differences between squamous cell carcinoma of the lung and bronchial epithelium. Mol. Cell. Proteomics 8, 1105-1116
27. Perkins, D. N., Pappin, D. J., Creasy, D. M., and Cottrell, J. S. (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551-3567 (Pubitemid 30007252)
28. Vizcaino, J. A., Cote, R. G., Csordas, A., Dianes, J. A., Fabregat, A., Foster, J. M., Griss, J., Alpi, E., Birim, M., Contell, J., O'Kelly, G., Schoenegger, A., Ovelleiro, D., Perez-Riverol, Y., Reisinger, F., Rios, D., Wang, R., and Hermjakob, H. (2013) The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 41, D1063-1069
29. Matos, J. M., Witzmann, F. A., Cummings, O. W., and Schmidt, C. M. (2009) A pilot study of proteomic profiles of human hepatocellular carcinoma in the United States. J. Surg. Res. 155, 237-43
30. Tzonou, A., Sparos, L., Kalapothaki, V., Zavitsanos, X., Rebelakos, A., and Trichopoulos, D. (1990) Alpha 1-antitrypsin and survival in hepatocellular carcinoma. Br. J. Cancer 61, 72-73 (Pubitemid 20043548)
31. Fargion, S., Klasen, E. C., Lalatta, F., Sangalli, G., Tommasini, M., and Fiorelli, G. (1981) Alpha 1-antitrypsin in patients with hepatocellular carcinoma and chronic active hepatitis. Clin. Genet. 19, 134-139 (Pubitemid 11136959)
32. Tartaglino, B., Macri, G., Molino, G., Furlani, D., and Sansalvadore, F. (1980) Behavior of serum alpha 1-antitrypsin in chronic hepatopathies and its diagnostic significance. Quad. Sclavo. Diagn. 16, 451-458
33. Kawakami, T., Hoshida, Y., Kanai, F., Tanaka, Y., Tateishi, K., Ikenoue, T., Obi, S., Sato, S., Teratani, T., Shiina, S., Kawabe, T., Suzuki, T., Hatano, N., Taniguchi, H., and Omata, M. (2005) Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment. Proteomics 5, 4287-4295 (Pubitemid 41626096)
34. Kang, X., Sun, L., Guo, K., Shu, H., Yao, J., Qin, X., and Liu, Y. (2010) Serum protein biomarkers screening in HCC patients with liver cirrhosis by ICAT-LC-MS/MS. J Cancer Res. Clin Oncol 136, 1151-9
35. Lee, H. B., Yoo, O. J., Ham, J. S., and Lee, M. H. (1992) Serum alpha 1-antitrypsin in patients with hepatocellular carcinoma. Clin. Chim. Acta 206, 225-2230
36. Sun, S., Poon, R. T., Lee, N. P., Yeung, C., Chan, K. L., Ng, I. O., Day, P. J., and Luk, J. M. (2010) Proteomics of hepatocellular carcinoma: serum vimentin as a surrogate marker for small tumors (
37. Song, H. Y., Liu, Y. K., Feng, J. T., Cui, J. F., Dai, Z., Zhang, L. J., Feng, J. X., Shen, H. L., and Tang, Z. Y. (2006) Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. J. Cancer Res. Clin. Oncol. 132, 92-98 (Pubitemid 41752050)
38. Srisomsap, C., Sawangareetrakul, P., Subhasitanont, P., Panichakul, T., Keeratichamroen, S., Lirdprapamongkol, K., Chokchaichamnankit, D., Sirisinha, S., and Svasti, J. (2004) Proteomic analysis of cholangiocarcinoma cell line. Proteomics 4, 1135-1144 (Pubitemid 38445971)
39. Gao, Q., Wang, X. Y., Fan, J., Qiu, S. J., Zhou, J., Shi, Y. H., Xiao, Y. S., Xu, Y., Huang, X. W., and Sun, J. (2008) Selection of reference genes for real-time PCR in human hepatocellular carcinoma tissues. J. Cancer Res. Clin. Oncol. 134, 979-986
40. Lau, W. Y., Lai, P. B., Leung, M. F., Leung, B. C., Wong, N., Chen, G., Leung, T. W., and Liew, C. T. (2000) Differential gene expression of hepatocellular carcinoma using cDNA microarray analysis. Oncol. Res. 12, 59-69
41. Kitamura, K., Hatano, E., Higashi, T., Narita, M., Seo, S., Nakamoto, Y., Yamanaka, K., Nagata, H., Taura, K., Yasuchika, K., Nitta, T., and Uemoto, S. (2011) Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis. J. Hepatol. 55, 846-857
42. Yi, X., Luk, J. M., Lee, N. P., Peng, J., Leng, X., Guan, X. Y., Lau, G. K., Beretta, L., and Fan, S. T. (2008) Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol. Cell. Proteomics 7, 315-325 (Pubitemid 351298446)
43. Kuramitsu, Y., and Nakamura, K. (2005) Current progress in proteomic study of hepatitis C virus-related human hepatocellular carcinoma. Expert Rev. Proteomics 2, 589-601 (Pubitemid 41139841)
44. Luk, J. M., Lam, C. T., Siu, A. F., Lam, B. Y., Ng, I. O., Hu, M. Y., Che, C. M., and Fan, S. T. (2006) Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics 6, 1049-1057 (Pubitemid 43260229)
45. Lim, S. O., Park, S. G., Yoo, J. H., Park, Y. M., Kim, H. J., Jang, K. T., Cho, J. W., Yoo, B. C., Jung, G. H., and Park, C. K. (2005) Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules. World J. Gastroenterol. 11, 2072-2079 (Pubitemid 40542649)
46. Su, R., Li, Z., Li, H., Song, H., Bao, C., Wei, J., and Cheng, L. (2010) Grp78 promotes the invasion of hepatocellular carcinoma. BMC Cancer 10, 20
47. Liaw, K. Y., Lee, P. H., Wu, F. C., Tsai, J. S., and Lin-Shiau, S. Y. (1997) Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. Am. J. Gastroenterol. 92, 2260-2263
48. Goldenberg, D., Ayesh, S., Schneider, T., Pappo, O., Jurim, O., Eid, A., Fellig, Y., Dadon, T., Ariel, I., de Groot, N., Hochberg, A., and Galun, E. (2002) Analysis of differentially expressed genes in hepatocellular carcinoma using cDNA arrays. Mol. Carcinog. 33, 113-124 (Pubitemid 34113200)
49. Li, Y., Wan, D., Wei, W., Su, J., Cao, J., Qiu, X., Ou, C., Ban, K., Yang, C., and Yue, H. (2008) Candidate genes responsible for human hepatocellular carcinoma identified from differentially expressed genes in hepatocarcinogenesis of the tree shrew (Tupaia belangeri chinesis). Hepatol. Res. 38, 85-95 (Pubitemid 350182580)
50. Kuo, W. H., Chiang, W. L., Yang, S. F., Yeh, K. T., Yeh, C. M., Hsieh, Y. S., and Chu, S. C., The differential expression of cytosolic carbonic anhydrase in human hepatocellular carcinoma. In Life Sci., 2003/08/21 ed.; 2003; Vol. 73, 2211-2223
51. Kinoshita, M., and Miyata, M. (2002) Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci. Hepatology 36, 433-438 (Pubitemid 34810364)
52. Liu, Y., Zhu, X., Zhu, J., Liao, S., Tang, Q., Liu, K., Guan, X., Zhang, J., and Feng, Z. (2007) Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray. Oncol. Rep. 18, 943-951
53. Park, K. S., Cho, S. Y., Kim, H., and Paik, Y. K. (2002) Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma. Int. J. Cancer 97, 261-265 (Pubitemid 34019964)
54. Hu, Y., Pang, E., Lai, P. B., Squire, J. A., MacGregor, P. F., Beheshti, B., Albert, M., Leung, T. W., and Wong, N. (2004) Genetic alterations in doxorubicin-resistant hepatocellular carcinoma cells: a combined study of spectral karyotyping, positional expression profiling and candidate genes. Int. J. Oncol. 25, 1357-1364
55. Kurokawa, Y., Matoba, R., Takemasa, I., Nakamori, S., Tsujie, M., Nagano, H., Dono, K., Umeshita, K., Sakon, M., Ueno, N., Kita, H., Oba, S., Ishii, S., Kato, K., and Monden, M. (2003) Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study. J. Hepatol. 39, 1004-1012 (Pubitemid 37523773)
56. Dillon, B. J., Prieto, V. G., Curley, S. A., Ensor, C. M., Holtsberg, F. W., Bomalaski, J. S., and Clark, M. A. (2004) Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation. Cancer 100, 826-833 (Pubitemid 38176863)
57. Peng, S. Y., Lai, P. L., Pan, H. W., Hsiao, L. P., and Hsu, H. C. (2008) Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis. Oncol. Rep. 19, 1045-1053
58. Lim, S. O., Park, S. J., Kim, W., Park, S. G., Kim, H. J., Kim, Y. I., Sohn, T. S., Noh, J. H., and Jung, G. (2002) Proteome analysis of hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 291, 1031-1037 (Pubitemid 34694379)
59. Seimiya, M., Tomonaga, T., Matsushita, K., Sunaga, M., Oh-Ishi, M., Kodera, Y., Maeda, T., Takano, S., Togawa, A., Yoshitomi, H., Otsuka, M., Yamamoto, M., Nakano, M., Miyazaki, M., and Nomura, F. (2008) Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase. Hepatology 48, 519-530
60. Na, K., Lee, E. Y., Lee, H. J., Kim, K. Y., Lee, H., Jeong, S. K., Jeong, A. S., Cho, S. Y., Kim, S. A., Song, S. Y., Kim, K. S., Cho, S. W., Kim, H., and Paik, Y. K. (2009) Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma. Proteomics 9, 3989-3999
61. Long, J., Lang, Z. W., Wang, H. G., Wang, T. L., Wang, B. E., and Liu, S. Q. (2010) Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas. Hepatobiliary Pancreat. Dis. Int. 9, 296-305
62. Chen, M., Zhang, J., Li, N., Qian, Z., Zhu, M., Li, Q., Zheng, J., Wang, X., and Shi, G. (2011) Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer. PLoS One 6, e25564
63. Avila, M. A., Berasain, C., Torres, L., Martin-Duce, A., Corrales, F. J., Yang, H., Prieto, J., Lu, S. C., Caballeria, J., Rodés, J., and Mato, J. M. (2000) Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J. Hepatol. 33, 907-914
64. Liang, C. R., Leow, C. K., Neo, J. C., Tan, G. S., Lo, S. L., Lim, J. W., Seow, T. K., Lai, P. B., and Chung, M. C. (2005) Proteome analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 5, 2258-2271 (Pubitemid 40770587)
65. Chen, Y. M., Shiu, J. Y., Tzeng, S. J., Shih, L. S., Chen, Y. J., Lui, W. Y., and Chen, P. H. (1998) Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma. Int. J. Cancer 75, 787-793 (Pubitemid 28145829)
66. Iizuka, N., Tsunedomi, R., Tamesa, T., Okada, T., Sakamoto, K., Hamaguchi, T., Yamada-Okabe, H., Miyamoto, T., Uchimura, S., Hamamoto, Y., and Oka, M. (2006) Involvement of c-myc-regulated genes in hepatocellular carcinoma related to genotype-C hepatitis B virus. J. Cancer Res. Clin. Oncol. 132, 473-481
67. Krapivner, S., Chernogubova, E., Ericsson, M., Ahlbeck-Glader, C., Hamsten, A., and van 't Hooft, F. M. (2007) Human evidence for the involvement of insulin-induced gene 1 in the regulation of plasma glucose concentration. Diabetologia 50, 94-102 (Pubitemid 46035858)
68. Wei, R. R., Zhang, M. Y., Rao, H. L., Pu, H. Y., Zhang, H. Z., and Wang, H. Y. (2012) Identification of ADH4 as a novel and potential prognostic marker in hepatocellular carcinoma. Med. Oncol. 29, 2737-2743
69. Costantino, E., Maddalena, F., Calise, S., Piscazzi, A., Tirino, V., Fersini, A., Ambrosi, A., Neri, V., Esposito, F., and Landriscina, M. (2009) TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells. Cancer Lett. 279, 39-46
70. Fang, W., Li, X., Jiang, Q., Liu, Z., Yang, H., Wang, S., Xie, S., Liu, Q., Liu, T., Huang, J., Xie, W., Li, Z., Zhao, Y., Wang, E., Marincola, F. M., and Yao, K. (2008) Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J. Transl. Med. 6, 32
71. Alvero, A. B., Chen, R., Fu, H. H., Montagna, M., Schwartz, P. E., Rutherford, T., Silasi, D. A., Steffensen, K. D., Waldstrom, M., Visintin, I., and Mor, G. (2009) Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 8, 158-166
72. Landriscina, M., Amoroso, M. R., Piscazzi, A., and Esposito, F. (2010) Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy. Gynecol. Oncol. 117, 177-182
73. Li, G. H., Arora, P. D., Chen, Y., McCulloch, C. A., and Liu, P. (2012) Multifunctional roles of gelsolin in health and diseases. Med. Res. Rev. 32, 999-1025
74. Blanc, J. F., Lalanne, C., Plomion, C., Schmitter, J. M., Bathany, K., Gion, J. M., Bioulac-Sage, P., Balabaud, C., Bonneu, M., and Rosenbaum, J. (2005) Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 5, 3778-3789 (Pubitemid 41393308)
75. Huang, J. S., Chao, C. C., Su, T. L., Yeh, S. H., Chen, D. S., Chen, C. T., Chen, P. J., and Jou, Y. S. (2004) Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 315, 950-958
76. Tomonaga, T., Matsushita, K., Yamaguchi, S., Oh-Ishi, M., Kodera, Y., Maeda, T., Shimada, H., Ochiai, T., and Nomura, F. (2004) Identification of altered protein expression and post-translational modifications in primary colorectal cancer by using agarose two-dimensional gel electrophoresis. Clin. Cancer Res. 10, 2007-2014 (Pubitemid 38375560)
77. Chen, G., Gharib, T. G., Huang, C. C., Thomas, D. G., Shedden, K. A., Taylor, J. M., Kardia, S. L., Misek, D. E., Giordano, T. J., Iannettoni, M. D., Orringer, M. B., Hanash, S. M., and Beer, D. G. (2002) Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin. Cancer Res. 8, 2298-2305 (Pubitemid 34753604)
78. Lexander, H., Palmberg, C., Auer, G., Hellstrom, M., Franzen, B., Jornvall, H., and Egevad, L. (2005) Proteomic analysis of protein expression in prostate cancer. Anal. Quant. Cytol. Histol. 27, 263-272 (Pubitemid 41504427)
79. Liang, R. C., Neo, J. C., Lo, S. L., Tan, G. S., Seow, T. K., and Chung, M. C. (2002) Proteome database of hepatocellular carcinoma. J. Chromatogr. B 771, 303-328 (Pubitemid 34457734)
80. Sitek, B., Sipos, B., Alkatout, I., Poschmann, G., Stephan, C., Schulenborg, T., Marcus, K., Luttges, J., Dittert, D. D., Baretton, G., Schmiegel, W., Hahn, S. A., Klöppel, G., Meyer, H. E., and Stühler, K. (2009) Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation. J. Proteome Res. 8, 1647-1656
81. Raidl, M., Berger, W., Schulte-Hermann, R., Kandioler-Eckersberger, D., Kappel, S., Wrba, F., Micksche, M., and Grasl-Kraupp, B. (2002) Expression of the lung resistance-related protein in human and rat hepatocarcinogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G1117-G1124 (Pubitemid 35192848)
82. Lara, P. C., Pruschy, M., Zimmermann, M., and Henriquez-Hernández, L. A. (2011) MVP and vaults: a role in the radiation response. Radiat. Oncol. 6, 148
83. Steiner, E., Holzmann, K., Pirker, C., Elbling, L., Micksche, M., Sutterlüty, H., and Berger, W. (2006) The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals. J. Cell Sci. 119, 459-469
84. Kolli, S., Zito, C. I., Mossink, M. H., Wiemer, E. A., and Bennett, A. M. (2004) The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J. Biol. Chem. 279, 29374-29385 (Pubitemid 38915816)
85. Berger, W., Steiner, E., Grusch, M., Elbling, L., and Micksche, M. (2009) Vaults and the major vault protein: novel roles in signal pathway regulation and immunity. Cell. Mol. Life Sci. 66, 43-61
86. Losert, A., Lötsch, D., Lackner, A., Koppensteiner, H., Peter-Vörösmarty, B., Steiner, E., Holzmann, K., Grunt, T., Schmid, K., Marian, B., Grasl-Kraupp, B., Schulte-Hermann, R., Krupitza, G., Berger, W., and Grusch, M. (2012) The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Lett. 319, 164-172
87. Pellanda, H., Namour, F., Fofou-Caillierez, M., Bressenot, A., Alberto, J. M., Chery, C., Ayav, A., Bronowicki, J. P., Gueant, J. L., and Forges, T. (2012) A splicing variant leads to complete loss of function of betaine-homocysteine methyltransferase (BHMT) gene in hepatocellular carcinoma. Int. J. Biochem. Cell Biol. 44, 385-392
88. Teng, Y. W., Mehedint, M. G., Garrow, T. A., and Zeisel, S. H. (2011) Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas. J. Biol. Chem. 286, 36258-36267
89. Di Tommaso, L., Franchi, G., Park, Y. N., Fiamengo, B., Destro, A., Morenghi, E., Montorsi, M., Torzilli, G., Tommasini, M., Terracciano, L., Tornillo, L., Vecchione, R., and Roncalli, M. (2007) Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 45, 725-734 (Pubitemid 46450624)